Stay updated on Psilocybin for Major Depression Clinical Trial
Sign up to get notified when there's something new on the Psilocybin for Major Depression Clinical Trial page.

Latest updates to the Psilocybin for Major Depression Clinical Trial page
- Check7 days agoChange DetectedThe 403 error message, breadcrumb labels, and NIH transition announcement are no longer displayed. The page is left with the site navigation and footer but little visible main content.SummaryDifference3%

- Check14 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0 while the study record page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA site-wide banner announces an NIH terminology transition, saying federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” and linking to updates and FAQs.SummaryDifference1%

- Check28 days agoChange DetectedThe footer's ClinicalTrials.gov revision identifier updates from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer’s displayed site revision changes from v3.7.0 to v3.7.1; the page otherwise remains a 403 Forbidden error page.SummaryDifference0.2%

- Check56 days agoChange Detected403 Forbidden error is rendered, replacing the full study record and related content with a generic error page. This blocks access to the study details, locations, and data submission information the page normally provides.SummaryDifference19%

Stay in the know with updates to Psilocybin for Major Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin for Major Depression Clinical Trial page.